Market Overview

Traders Circulating Apparently Leaked Doc from Dept. of Health and Human Services Showing FDA Has Ruled to Withdraw NDA for Acthar Synthetic, Citing Safety, Effectiveness; Mallinckrodt Shares Unjustifiably React